biosimilar monoclonal antibodies

Biosimilar monoclonal antibodies are nearly identical copies of original biologic drugs, which are complex proteins used to treat conditions like cancer or autoimmune diseases. Created after the original drug’s patent expires, biosimilars undergo rigorous testing to ensure they are as safe and effective as the original. They offer similar therapeutic benefits but often at a lower cost, increasing access to important treatments. Because they are similar but not exact copies, they are carefully regulated to maintain high standards of quality, safety, and efficacy for patients.